Comment from Prateek Yadav

Summary: The commenter supports the draft guidance as a necessary step for regulating impurities in fermentation- and semi-synthesis-derived antibiotics but argues that the scope should be expanded. They specifically advocate for including requirements to identify and control "interaction impurities" that occur in combination antibiotic drug products containing multiple active pharmaceutical ingredients.